These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9865322)

  • 1. FK-506 (tacrolimus) therapy for an unusual SLE-like disease.
    Kilian K; Banyai A; Karadi A; Miklos K; Patranyi GG; Paloczi K
    Transplant Proc; 1998 Dec; 30(8):4130-1. PubMed ID: 9865322
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.
    Yoon KH
    J Biomed Biotechnol; 2010; 2010():686480. PubMed ID: 20625508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do immunosuppressives upregulate antiphospholid antibodies?
    Korkmaz C
    J Rheumatol; 2009 Feb; 36(2):447-8; author reply 448-9. PubMed ID: 19208575
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-S alloantibody underlying pan agglutinating autoantibody in a patient of systemic lupus erythematosus: a case report.
    Pahuja S; Sethi N; Gurtoo A; Kumar Pande A; Chaudhary P; Jain M
    Iran J Immunol; 2011 Mar; 8(1):58-63. PubMed ID: 21427497
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
    Schulman S; Langevitz P; Livneh A; Mortinowitz U; Seligsohn U; Varon D
    Thromb Haemost; 1996 Sep; 76(3):344-6. PubMed ID: 8883268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine, FK-506, rapamycin, and other immunomodulators.
    Yocum DE
    Rheum Dis Clin North Am; 1996 Feb; 22(1):133-54. PubMed ID: 8907069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection.
    Tomita H; Yamada M; Sekigawa I; Yoshiike T; Iida N; Hashimoto H
    Clin Exp Rheumatol; 2003; 21(4):497-9. PubMed ID: 12942705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS; Johnson JL; Elliott-Mills D; Opas LM
    Lupus; 1997; 6(3):275-8. PubMed ID: 9104736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls.
    Stone JH; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Aug; 41(8):1438-45. PubMed ID: 9704643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus- (FK 506) based immunosuppression in severe systemic lupus erythematosus.
    Politt D; Heintz B; Floege J; Mertens PR
    Clin Nephrol; 2004 Jul; 62(1):49-53. PubMed ID: 15267013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type B insulin resistance complicated with systemic lupus erythematosus.
    Kawashiri SY; Kawakami A; Fujikawa K; Iwamoto N; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
    Intern Med; 2010; 49(5):487-90. PubMed ID: 20190490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine in the treatment of autoimmune disorders: a 10-year experience.
    Mitrovic D; Popovic M; Glisic B; Pavlica L; Dimitrijevic M
    Transplant Proc; 1998 Dec; 30(8):4134. PubMed ID: 9865324
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases.
    Duddridge M; Powell RJ
    Ann Rheum Dis; 1997 Nov; 56(11):690-2. PubMed ID: 9462174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of Satoyoshi syndrome with tacrolimus and corticosteroids.
    Endo K; Yamamoto T; Nakamura K; Hoshi A; Yamanoi T; Watanabe A; Homma M
    Neurology; 2003 Jun; 60(12):2014-5. PubMed ID: 12821760
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.
    Pang M; Setoyama Y; Tsuzaka K; Yoshimoto K; Amano K; Abe T; Takeuchi T
    Clin Exp Immunol; 2002 Jul; 129(1):160-8. PubMed ID: 12100036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immunoglobulin dysregulation in graft versus host-and systemic lupus erythematosus-like diseases by malononitrilamides.
    Schorlemmer HU; Bartlett RR
    Transplant Proc; 1998 Dec; 30(8):4153-5. PubMed ID: 9865331
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.
    Yamasaki Y; Narain S; Hernandez L; Barker T; Ikeda K; Segal MS; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Res Ther; 2006; 8(4):R111. PubMed ID: 16846524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of systemic autoimmune disorders & autoantibodies in house-hold contacts of patients with systemic lupus erythematosus.
    Aggarwal A; Singh RR; Kumar A; Misra R; Malaviya AN
    Indian J Med Res; 1991 Apr; 94():96-8. PubMed ID: 1879893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.